Lentiviral gene therapy for HIV using TRIM-cyclophilin restriction factors

Lentiviral gene therapy for HIV using TRIM-cyclophilin restriction factors

Lentiviral vector delivery of anti-HIV elements could provide the basis of alternative therapies against HIV, potentially providing long term protection after a single intervention. Some primate species have evolved restriction factors formed by the fusion of TRIM5α and Cyclophilin A (TRIM5Cyp) foll...

Full description

Bibliographic Details
Main Author:	Chan, E.
Published:	University College London (University of London) 2012
Subjects:	616
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.568277

Similar Items

Lentiviral vectors for gene therapy
by: Knight, S. B.
Published: (2012)

Characterising retroviral restriction by TRIM proteins
by: Fraser, S. J.
Published: (2016)

Characterisation of TRIM5α and related retroviral restriction factors
by: Schaller, T.
Published: (2009)

Gene Therapy Strategies to Exploit TRIM Derived Restriction Factors against HIV-1
by: Emma Chan, et al.
Published: (2014-01-01)

Characterisation of variations in the TRIM5a HIV restriction pathway that correlate with HIV-2 disease progression
by: Onyango, Clayton Ondu
Published: (2010)

Advancing lentiviral gene therapy vectors for β-thalassaemia
by: Stephanou, Coralea
Published: (2015)

Cyclophilin A interacts with diverse lentiviral capsids
by: Emerman Michael, et al.
Published: (2006-10-01)

Development and application of non-integrating lentiviral vectors for gene therapy
by: Apolonia, L. F. S.
Published: (2009)

Integration-deficient lentiviral vectors delivering neurotrophic factors for gene therapy of Parkinson's disease
by: Lu-Nguyen, Ngoc Bao
Published: (2013)

Cyclophilin A Prevents HIV-1 Restriction in Lymphocytes by Blocking Human TRIM5α Binding to the Viral Core
by: Anastasia Selyutina, et al.
Published: (2020-03-01)

HIV-1 Evasion of Human TRIM5α via Cyclophilin A
by: Kim, Kyusik
Published: (2020)

Lentiviral vectors as tools for gene manipulation
by: Godfrey, Andrew Robert
Published: (2006)

Development of a liver gene therapy strategy for haemophilia B with lentiviral vectors
by: Cantore, Alessio
Published: (2012)

Lentiviral TCR gene transfer for tumour immunotherapy
by: Perro, M.
Published: (2010)

Regulation of TRIM E3 Ligases and Cyclophilin A and the impact on HIV-1 replication and pathogenesis.
by: Singh, Ravesh.
Published: (2013)

Lentiviral-mediated gene delivery to investigate the functional role of neuropsychiatric genes
by: Fernandes, Alinda
Published: (2013)

Production of self-inactivating lentiviral vectors by constitutive packaging cell lines for gene therapy clinical applications
by: Sanber, K. S. R.
Published: (2015)

Consequences of persistent antigen presentation following administration of HIV-1-derived lentiviral vectors
by: Arce Vargus, F.
Published: (2010)

Lentiviral vectors for treatment of haemophilia
by: Ward, N. J.
Published: (2010)

Characterisation of lentiviral Vpr function and mechanism
by: Van Tulleken, C. R.
Published: (2017)

Cyclophilin A potentiates TRIM5α inhibition of HIV-1 nuclear import without promoting TRIM5α binding to the viral capsid.
by: Mallori Burse, et al.
Published: (2017-01-01)

Study of cyclophilin A function in models of amyotrophic lateral sclerosis
by: Lauranzano, Eliana
Published: (2012)

Trafficking of primate lentiviral envelope proteins
by: Byland, Rahel
Published: (2006)

The Study of Neutrophil Function using stem cells and lentiviral Technology
by: Dick, Emily Patricia
Published: (2008)

Role of cyclophilins and heat shock proteins in myocardial ischaemia/reperfusion injury
by: Folarin, Najeem'deen Ildeon
Published: (2004)

The antiviral spectra of TRIM5α orthologues and human TRIM family proteins against lentiviral production.
by: Seiga Ohmine, et al.
Published: (2011-01-01)

TRIM32 in Genetic Disease
by: Locke, Matthew
Published: (2009)

10 The interferon-inducible restriction factor TRIM22 contributes to HIV-1 latency
by: F. Turrini, et al.
Published: (2016-07-01)

Lentiviral vector vaccines for T-cell-mediated protection against influenza
by: Macdonald, D.
Published: (2014)

Expression of APOBEC3 Lentiviral Restriction Factors in Cats
by: Ryan M. Troyer, et al.
Published: (2019-09-01)

Cancer vaccines : using lentiviral vectors to deliver antigens to dendritic cells in vivo
by: Rowe, Helen
Published: (2006)

Critical parameters and molecular analysis of lentiviral vector-mediated gene transfer into human haematopoietic stem cells
by: Santoni de Sio, Francesca Romana
Published: (2006)

TRIM34 restricts HIV-1 and SIV capsids in a TRIM5α-dependent manner.
by: Molly Ohainle, et al.
Published: (2020-04-01)

Developing lentiviral tools to generate and characterise induced pluripotent stem cells
by: Kelly, Maebh
Published: (2012)

Variations in Trim5α and Cyclophilin A genes among HIV-1 elite controllers and non controllers in Uganda: a laboratory-based cross-sectional study
by: Sharon Bright Amanya, et al.
Published: (2020-07-01)

Expression of TRIM genes in different immune cells and mechanism of regulation of their expression : implications for the immune response to pathogens
by: Rajsbaum, Ricardo
Published: (2009)

Mechanism of action of cyclosporine A in atopic eczema and role of cyclophilin B as a regulator of human keratinocyte growth and differentiation
by: Sinha, Aparna
Published: (2015)

Characterisation of a post-entry restriction to HIV in human cells
by: Marchant, David
Published: (2005)

Transcriptional targeting of lentiviral vectors to the erythroblastic progeny of hematopoietic stem cells
by: Lotti, Francesco
Published: (2003)

Lentiviral Vectors and Cystic Fibrosis Gene Therapy
by: Massimo Conese, et al.
Published: (2010-01-01)

Cannot write session to /tmp/vufind_sessions/sess_md0gntfkk2g2mlbr28paujk07i